Wear OS watches might soon have an edge when it comes to blood oxygen
Masimo is keen to offer its expertise to Wear OS smartwatch makers for biosensing tech. | Photo by Amelia Holowaty Krales / The Verge
Last week, medical device maker Masimo announced new deals with Google and Qualcomm to bring its biosensing tech to Wear OS smartwatches. That’s pretty inside baseball for the wearable industry, but it takes an interesting turn when you realize Masimo is also the reason why the new Apple Watch Series 10 doesn’t have blood oxygen features in the U.S.
From the outside, it sort of looks like the company battling Apple over blood oxygen is now setting the terms for how that exact tech is used by Apple’s smartwatch rivals. Securing the bag, so to speak, against other alleged patent infringement.
Masimo CEO Joe Kiani says that’s not exactly how he sees it. As part of the deals, Masimo is creating a reference platform where its tech is...
Continue reading…
Welcome to Billionaire Club Co LLC, your gateway to a brand-new social media experience! Sign up today and dive into over 10,000 fresh daily articles and videos curated just for your enjoyment. Enjoy the ad free experience, unlimited content interactions, and get that coveted blue check verification—all for just $1 a month!
Account Frozen
Your account is frozen. You can still view content but cannot interact with it.
Please go to your settings to update your account status.
Open Profile Settings